# TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease

> **NCT02879136** · EARLY_PHASE1 · COMPLETED · sponsor: **Hubert Fernandez** · enrollment: 23 (actual)

## Conditions studied

- Parkinson's Disease, Idiopathic

## Interventions

- **DRUG:** Methylphenidate
- **OTHER:** Physical Therapy
- **DRUG:** Atomoxetine

## Key facts

- **NCT ID:** NCT02879136
- **Lead sponsor:** Hubert Fernandez
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-03
- **Primary completion:** 2025-12-12
- **Final completion:** 2025-12-12
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02879136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02879136, "TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02879136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*